File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Justice in control of methicillin-resistant Staphylococcus aureus transmission: a fair question to ask?

TitleJustice in control of methicillin-resistant Staphylococcus aureus transmission: a fair question to ask?
Authors
KeywordsActive surveillance
Antibiotic resistance
Asymptomatic carriers
Contact precautions
Ethics
Infection control
Justice
Methicillin-resistant Staphylococcus aureus
MRSA
Public health
Issue Date1-Jul-2020
PublisherSpringer
Citation
Monash Bioethics Review, 2020, v. 38, p. 56-71 How to Cite?
Abstract

Active surveillance cultures and contact precautions is a strategy to control the transmission of methicillin-resistant Staphylococcus aureus (MRSA) within healthcare facilities. Whether to implement this strategy to routinely screen and isolate inpatients with MRSA in non-outbreak (endemic) settings, or to remove it and use standard infection control precautions only is scientifically and ethically controversial, in view of the potential adverse effects of contact precautions on patients. To support the use of standard precautions only, it has been argued that active surveillance to identify patients who are asymptomatically colonised with MRSA to place them in contact precautions is unjust or unfair to these patients in various ways. This paper will unpack and examine four distinct arguments, which are advanced from a medical ethics or quality improvement ethical framework, for why this is so. Our analysis shows that while these arguments highlight the injustice of current practices, they do not provide strong ethical reasons for justifying the removal of active surveillance and contact precautions to control MRSA transmission and infection. An implication of our arguments is that the ethical frame for evaluating prevention and control strategies for MRSA, a multi-drug resistant bacteria, should shift from healthcare to primarily public health. From a public health ethics perspective, whether a strategy is unjust, or how ethically significant its lack of fairness is, depends on assessing the evidence for its public health effectiveness and necessity in a given setting, and the extent of the harms and burdens patients with MRSA bear when they are on contact precautions, which remain matters of scientific debate or uncertainty. As an ethical consideration in the debate, the chief normative implication of justice is to provide us further reasons to revise current active surveillance-contact precautions practices, and for the need for research and interventions to minimise their potential adverse effects on patients.


Persistent Identifierhttp://hdl.handle.net/10722/356943
ISSN
2023 Impact Factor: 1.6
2023 SCImago Journal Rankings: 0.415
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorVoo, Teck Chuan-
dc.contributor.authorLederman, Zohar-
dc.date.accessioned2025-06-23T08:52:35Z-
dc.date.available2025-06-23T08:52:35Z-
dc.date.issued2020-07-01-
dc.identifier.citationMonash Bioethics Review, 2020, v. 38, p. 56-71-
dc.identifier.issn1321-2753-
dc.identifier.urihttp://hdl.handle.net/10722/356943-
dc.description.abstract<p> <span>Active surveillance cultures and contact precautions is a strategy to control the transmission of methicillin-resistant Staphylococcus aureus (MRSA) within healthcare facilities. Whether to implement this strategy to routinely screen and isolate inpatients with MRSA in non-outbreak (endemic) settings, or to remove it and use standard infection control precautions only is scientifically and ethically controversial, in view of the potential adverse effects of contact precautions on patients. To support the use of standard precautions only, it has been argued that active surveillance to identify patients who are asymptomatically colonised with MRSA to place them in contact precautions is unjust or unfair to these patients in various ways. This paper will unpack and examine four distinct arguments, which are advanced from a medical ethics or quality improvement ethical framework, for why this is so. Our analysis shows that while these arguments highlight the injustice of current practices, they do not provide strong ethical reasons for justifying the removal of active surveillance and contact precautions to control MRSA transmission and infection. An implication of our arguments is that the ethical frame for evaluating prevention and control strategies for MRSA, a multi-drug resistant bacteria, should shift from healthcare to primarily public health. From a public health ethics perspective, whether a strategy is unjust, or how ethically significant its lack of fairness is, depends on assessing the evidence for its public health effectiveness and necessity in a given setting, and the extent of the harms and burdens patients with MRSA bear when they are on contact precautions, which remain matters of scientific debate or uncertainty. As an ethical consideration in the debate, the chief normative implication of justice is to provide us further reasons to revise current active surveillance-contact precautions practices, and for the need for research and interventions to minimise their potential adverse effects on patients.</span> <br></p>-
dc.languageeng-
dc.publisherSpringer-
dc.relation.ispartofMonash Bioethics Review-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectActive surveillance-
dc.subjectAntibiotic resistance-
dc.subjectAsymptomatic carriers-
dc.subjectContact precautions-
dc.subjectEthics-
dc.subjectInfection control-
dc.subjectJustice-
dc.subjectMethicillin-resistant Staphylococcus aureus-
dc.subjectMRSA-
dc.subjectPublic health-
dc.titleJustice in control of methicillin-resistant Staphylococcus aureus transmission: a fair question to ask?-
dc.typeArticle-
dc.identifier.doi10.1007/s40592-020-00109-x-
dc.identifier.scopuseid_2-s2.0-85114385005-
dc.identifier.volume38-
dc.identifier.spage56-
dc.identifier.epage71-
dc.identifier.eissn1836-6716-
dc.identifier.isiWOS:000526229900001-
dc.identifier.issnl1321-2753-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats